LFMDNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as LFMDP

LifeMD, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026

$2.25−0.09 (-3.85%)

Close on Oct 19, 2026

Market cap: $107.52M
P/E (TTM): –
Dividend yield: –

Dividends

LifeMD has not reported a dividend

No dividend per share appears in LifeMD's annual filings since fiscal 2011.

Where these numbers come from

Parsed from the XBRL in LifeMD's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-5 reverse split on Nov 16, 2020
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is LFMD.

Revenue growth3.8% · median -2.1%

Gross margin86.1% · median 68.7%

Operating margin-14.7% · median -6.0%

Net margin0.1% · median -6.2%

Company	Revenue	Growth
HIMS	$2.58B	+28.0%
TDOC	$2.49B	-2.1%
STLN	$587.24M	+38.4%
SBC	$175.17M	-6.9%
LFMD	$164.70M	+3.8%
AIRS	$150.72M	-8.7%

Company

Next earnings (est.): Nov 16, 2026, after close
Exchange: Nasdaq
Industry: Services-Offices & Clinics of Doctors of Medicine
Fiscal year ends: December 31
Employees: 389
Auditor: Marcum LLP
SEC CIK: 948320

Advertisement
300 × 250